Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Penederm and SmithKline Beecham announce OTC collaboration

April 10, 1997

New thrombin receptor cloned and characterized

April 10, 1997

Small-molecule drug discovery collaboration between Chiroscience and Alcon

April 9, 1997

Aradigm's SmartMist covered by U.S. patent

April 9, 1997

NIH seeks licensees for method of characterizing/screening/detecting DNA-binding ligands

April 9, 1997

Abgenix, JT and GenPharm sign crosslicensing agreement for human MAb technologies

April 7, 1997

Novel drug delivery system from Brown University shows promise

April 4, 1997

Electroporation shown to be effective for local delivery of agents for restenosis

April 3, 1997

Sheffield licenses Siemens multidose inhaler

April 3, 1997

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...